Clinician-directed care
Clinician-directed care has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 26, 2026: “Serial photon-counting CCTA reveals the natural history of high-risk plaques in patients after ACS”.
1 paper studies it2 findingsUpdated
1 new paper in 30 daysSee all 1
“HRP prevalence did not change (51% vs 45%, P=0.40)”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of Clinician-directed care find?
2Studies of Clinician-directed care measured 2 outcomes; the most studied are low-attenuation plaque frequency (1 study) and high-risk plaque prevalence (1).
Low-attenuation plaque frequency
downin humans1
1 study
Low-attenuation plaque frequency
downin humans1
Clinician-directed care is linked with lower low-attenuation plaque frequency in humans (clinician-directed care post-ACS) (63% vs 56%, P=0.0005).
“there was a decrease in the frequency of low-attenuation plaque (63% vs 56%, P=0.0005)”
Humansclinician-directed care post-ACS12 monthsn = 100
Serial photon-counting CCTA reveals the natural history of high-risk plaques in patients after ACS
ESC Congress 2026 abstract
High-risk plaque prevalence
no changein humans1
1 study
High-risk plaque prevalence
no changein humans1
Clinician-directed care was not clearly linked with high-risk plaque prevalence in humans (clinician-directed care post-ACS) (51% vs 45%, P=0.40).
“HRP prevalence did not change (51% vs 45%, P=0.40)”
Humansclinician-directed care post-ACS12 monthsn = 100
Serial photon-counting CCTA reveals the natural history of high-risk plaques in patients after ACS
ESC Congress 2026 abstract